scholarly journals Respiratory Virus in Cystic Fibrosis — A Review of the Literature

10.5772/60905 ◽  
2015 ◽  
Author(s):  
Dennis Wat
Keyword(s):  
Cystic Fibrosis ◽  
Respiratory Virus ◽  
Review Of The Literature

Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature

Mycoses ◽  
2021 ◽  
Author(s):  
Mohanad Al‐Obaidi ◽  
Hamid Badali ◽  
Connie Cañete‐Gibas ◽  
Hoja P. Patterson ◽  
Nathan P. Wiederhold
Keyword(s):  
Cystic Fibrosis ◽  
Cystic Fibrosis Patient ◽  
Pulmonary Infection ◽  
Review Of The Literature

scholarly journals Once Daily Dosing of Aminoglycosides in Pediatric Cystic Fibrosis Patients: A Review of the Literature

2008 ◽  
Vol 13 (2) ◽  
pp. 68-75
Author(s):  
Sarah K. Wassil ◽  
Kristie M. Fox ◽  
James W. White
Keyword(s):  
Cystic Fibrosis ◽  
Review Of The Literature ◽  
Nursing Time ◽  
Once Daily ◽  
Development Of Resistance ◽  
Cystic Fibrosis Population ◽  
Antibiotic Effect ◽  
Home Administration ◽  
Post Antibiotic Effect

Patients with cystic fibrosis receive many courses of antibiotic therapy throughout their lifetime. Dosing aminoglycosides once daily has become common practice in many of these individuals. Due to ease of home administration, decreased nursing time, and improved quality of life, this regimen is being increasingly explored in the cystic fibrosis population. Because patients with cystic fibrosis have increased aminoglycoside clearance, once daily dosing may result in a prolonged time during the dosing interval when concentrations of the drug may be undetectable. This makes the use of once daily dosing of these antibiotics in patients with cystic fibrosis controversial. Although aminoglycosides exhibit a post antibiotic effect, the duration of this effect is unknown in humans; therefore, the development of resistance to the aminoglycoside is a concern. This manuscript will review the organisms most commonly associated with a pulmonary exacerbation of cystic fibrosis, the properties of the aminoglycoside that make once daily dosing feasible, the concept of once daily dosing in those with cystic fibrosis and the current literature regarding efficacy, monitoring, toxicity and concerns of resistance with once daily dosing in this population.

scholarly journals Double homozygous Cystic Fibrosis Transmembrane Regulator gene (CFTR) mutation: A case series and review of the literature

2020 ◽  
pp. 015-021
Author(s):  
Banjar Hanaa ◽  
Alkassas Wesam ◽  
Ghomraoui Firas ◽  
Ghomraoui Reem ◽  
Moghrabi Nabil
Keyword(s):  
Cystic Fibrosis ◽  
Case Series ◽  
Cystic Fibrosis Transmembrane Regulator ◽  
Regulator Gene ◽  
Review Of The Literature ◽  
Cystic Fibrosis Transmembrane ◽  
Gène Cftr

scholarly journals Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature

Lung India ◽  
2020 ◽  
Vol 37 (2) ◽  
pp. 161 ◽  
Author(s):  
Nurhayat Yakut ◽  
EdaKepenekli Kadayifci ◽  
ElaErdem Eralp ◽  
Yasemin Gokdemir
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Successful Treatment ◽  
Allergic Bronchopulmonary Aspergillosis ◽  
Review Of The Literature

scholarly journals c.753_754delAG, a novel CFTR mutation found in a Chinese patient with cystic fibrosis: A case report and review of the literature

2019 ◽  
Vol 7 (15) ◽  
pp. 2110-2119
Author(s):  
Yu-Qing Wang ◽  
Chuang-Li Hao ◽  
Wu-Jun Jiang ◽  
Yan-Hong Lu ◽  
Hui-Quan Sun ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Chinese Patient ◽  
Review Of The Literature

scholarly journals Digging through the Obstruction: Insight into the Epithelial Cell Response to Respiratory Virus Infection in Patients with Cystic Fibrosis

2016 ◽  
Vol 90 (9) ◽  
pp. 4258-4261 ◽  
Author(s):  
Matthew R. Hendricks ◽  
Jennifer M. Bomberger
Keyword(s):  
Cystic Fibrosis ◽  
Lung Diseases ◽  
Respiratory Virus ◽  
Viral Infections ◽  
Molecular Diagnostic ◽  
Molecular Diagnostic Techniques ◽  
Virus Infections ◽  
Chronic Lung Diseases ◽  
Respiratory Viral Infections ◽  
Respiratory Virus Infections

Respiratory virus infections are common but generally self-limiting infections in healthy individuals. Although early clinical studies reported low detection rates, the development of molecular diagnostic techniques by PCR has led to an increased recognition that respiratory virus infections are associated with morbidity and acute exacerbations of chronic lung diseases, such as cystic fibrosis (CF). The airway epithelium is the first barrier encountered by respiratory viruses following inhalation and the primary site of respiratory viral replication. Here, we describe how the airway epithelial response to respiratory viral infections contributes to disease progression in patients with CF and other chronic lung diseases, including the role respiratory viral infections play in bacterial acquisition in the CF patient lung.

Contraception in women with cystic fibrosis: a systematic review of the literature

Contraception ◽  
2016 ◽  
Vol 93 (1) ◽  
pp. 3-10 ◽  
Author(s):  
Andrea Hsu Roe ◽  
Sarah Traxler ◽  
Courtney A. Schreiber
Keyword(s):  
Systematic Review ◽  
Cystic Fibrosis ◽  
Review Of The Literature

The pathology of fibrosing colonopathy of cystic fibrosis: A study of 12 cases and review of the literature

1997 ◽  
Vol 28 (4) ◽  
pp. 395-399 ◽  
Author(s):  
Bruce R Pawel ◽  
Jean-Pierre de Chadarévian ◽  
Maria E Franco
Keyword(s):  
Cystic Fibrosis ◽  
Review Of The Literature ◽  
Fibrosing Colonopathy

Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature

2008 ◽  
Vol 9 (5) ◽  
pp. 751-766 ◽  
Author(s):  
Jennifer R Weiner ◽  
Edmond L Toy ◽  
Patricia Sacco ◽  
Mei Sheng Duh
Keyword(s):  
Quality Of Life ◽  
Cystic Fibrosis ◽  
Treatment Compliance ◽  
Review Of The Literature
Sign in / Sign up

Export Citation Format

Share Document